Sign In
Buy IBB
$167.50
+3.23 (+1.97%)
At Close: Jun 03, 2026
Merit Financial Group LLC Reduces Stock Holdings in iShares Biotechnology ETF $IBB
05:20am, Wednesday, 07'th Jan 2026
Merit Financial Group LLC lowered its holdings in iShares Biotechnology ETF (NASDAQ: IBB) by 53.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Co
Bigelow Investment Advisors LLC Has $505,000 Holdings in iShares Biotechnology ETF $IBB
04:34am, Monday, 05'th Jan 2026
Bigelow Investment Advisors LLC trimmed its position in iShares Biotechnology ETF (NASDAQ: IBB) by 48.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exch
Mizuho's Jared Holz on what biotech dealmaking looks like in 2026
02:27pm, Wednesday, 31'st Dec 2025
Jared Holz, Mizuho health care equity strategist, joins 'The Exchange' to discuss the surge in pharma M&A in 2025, ACA subsidies expiring, and more.
Analyst IMS Investment Management Services Ltd. Trims Stock Position in iShares Biotechnology ETF $IBB
03:21am, Tuesday, 30'th Dec 2025
Analyst IMS Investment Management Services Ltd. trimmed its stake in iShares Biotechnology ETF (NASDAQ: IBB) by 31.3% during the third quarter, according to its most recent 13F filing with the Securit
Why This Fund Cashed Out of a $3.6 Million Biotech ETF Bet
03:53pm, Friday, 26'th Dec 2025
Kentucky-based Aristides Capital sold 28,467 shares of IBB in the third quarter. The shares were worth an estimated $3.60 million.
2 Top Growth Themes Beyond AI and How to Invest in Them
11:52am, Friday, 26'th Dec 2025
The AI trade has been wobbling quite a bit in recent weeks, to say the least. And while the popping of the AI bubble hasn't yet happened, it does seem like much of the damage done to particular overhe
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:22am, Friday, 26'th Dec 2025
A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market.
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
02:04pm, Tuesday, 23'rd Dec 2025
The approval of Novo Nordisk's (NYSE: NVO)oral Wegovy is bringing new interest to health care and pharmaceutical ETFs that provide access to the growing GLP-1 market without requiring investors to cho
This year's biotech laggards primed for 2026 recovery, says Goldman Sachs' Richter
06:25pm, Friday, 19'th Dec 2025
CNBC's “Closing Bell Overtime” team discusses why the biotech recovery may continue into 2026 with Salveen Richter, lead U.S. biotech analyst at Goldman Sachs Research.
Should You Invest in the iShares Biotechnology ETF (IBB)?
07:21am, Monday, 15'th Dec 2025
Launched on February 5, 2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity mar
2 Brilliant Biotech ETFs to Watch in 2026
10:58am, Sunday, 14'th Dec 2025
As the AI trade gets overheated and calls for some sort of bursting of the AI bubble grow louder, it might make sense to look to opportunities to be had within other sectors.
3 Potential Mid-Cap Biotech Buyout Targets In 2026
06:22pm, Wednesday, 03'rd Dec 2025
The biotech sector began December with notable weakness, as both IBB and XBI ETFs declined over two percent during trading on Monday. The sector has bounced back since. However, small biotech stocks
AI Just Sparked Biotech's Biggest Rally Since 2004 — Why Isn't Anyone Talking About It?
03:14pm, Tuesday, 25'th Nov 2025
While most eyes are on tech and chipmakers, biotech is quietly staging its biggest rally in over two decades.
Inside the Recent Strength in Biotech ETFs
09:01am, Friday, 21'st Nov 2025
Biotech strength is back, with IBB, PBE, FBT, CANC and HELX climbing as cheaper valuations, rate-cut hopes, FDA approvals and strong deal activity fuel biotech gains.
Bronte Capital Management Pty Ltd. Grows Stock Holdings in iShares Biotechnology ETF $IBB
04:05am, Thursday, 20'th Nov 2025
Bronte Capital Management Pty Ltd. increased its stake in iShares Biotechnology ETF (NASDAQ: IBB) by 12.6% during the undefined quarter, according to its most recent disclosure with the Securities and
